This Dinosaur Probably Tweeted More Than It Roared
In a paper published last week in the journal PeerJ, researchers announced the discovery of a fossilized herbivorous dinosaur from China preserving a surprisingly birdlike throat. It provides a clue that the origins of birdsong might go as far back as the beginning of dinosaurs themselves.
The two-foot-long dinosaur, which the researchers named Pulaosaurus, was discovered in 163-million-year-old rocks in northeastern China, said Xing Xu, a paleontologist at the Chinese Academy of Sciences in Beijing and an author of the paper. The largely complete skeleton offers a strong anatomical view into the fleet-footed, beaked animal, an early member of the family that later produced 'duck-billed' hadrosaurs and horned dinosaurs.
The Jurassic period formation that produced Pulaosaurus is also the source of other dinosaur discoveries like the feathered proto-bird Anchiornis, the tiny, batlike Yi qi and the feathered herbivorous dinosaur Tianyulong. Unlike those animals, Pulaosaurus is not preserved with obvious soft tissues that could help better explain its living appearance. 'On some parts of the fossil we thought we'd found very thin filaments, but we can't confirm that,' Dr. Xu said.
The team did note interesting formations in the stomach region of the fossil but hasn't determined what those are. 'They could be stomach contents — food eaten by this dinosaur, or organs, or maybe even eggs within the body,' Dr. Xu said.
The most interesting remains were found within the throat. In vertebrates, vocal organs play an important role in protecting the airway and helping produce everything from simple hisses and grunts to speech. In most living reptiles, these tissues are composed of cartilage, and can produce simple bellows, grunts, groans and chirps. Modern birds have vocal organs made up partially of delicate bones, allowing them to make much more complicated sounds — including, in some cases, mimicking human speech.
Want all of The Times? Subscribe.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
Scientists Find Secret Code in Human DNA
One person's junk is another's treasure. An international team of scientists have found that strings of "junk" DNA in the human genome that were previously written off as having no useful function are actually pretty important after all. The work, published as a study in the journal Science Advances, focuses on transposable elements, a class of DNA sequences that can "jump," via a biological copy-and-paste mechanism, to different locations in a genome. These "jumping genes" take up nearly 50 percent of human DNA; in other organisms, the proportion is even higher. What the researchers from Japan, China, Canada, and the US found is that a particular family of these TEs, called MER11, can strongly influence gene expression and act like "genetic switches" — without actually changing the underlying DNA. "Our genome was sequenced long ago, but the function of many of its parts remain unknown," study coauthor Fumitaka Inoue from Kyoto University said in a statement about the work. MER11 sequences are what's known as long terminal repeat (LTR) retrotransposons. Spookily, these are believed to have originated from an endogenous retrovirus (ERV) that infected a simian ancestor tens of millions of years ago, hijacking the DNA of the cells it invaded to produce copies of its genetic makeup that have never gone away, but have largely remained inert. Per the researchers, at least eight percent of the human genome comes from these retroviruses. That, plus all the other TEs littering our genome, makes for a lot of puzzling clutter for human scientists to sift through. The authors argue that the current methods for classifying and annotating TEs are inaccurate, leading to DNA sequences being overlooked as genetic junk. This inspired them to test their own classification system. "The proper classification and annotation of LTR instances is critical to understanding their evolution, co-option and potential impact on the host," the authors wrote in the study. The researchers' system classified MER11 sequences based on their evolutionary relationships and how well they were preserved in primate genomes, according to the researchers' statement. Then, they divided MER11 into four separate subfamilies, MER11_G1 through G4, based on their age. This allowed the team to compare the MER11 subfamilies to what are known as epigenetic marks: chemicals that can affect how important proteins function, and as a consequence affect gene activity. Crucially, epigenetic marks don't have to physically alter a cell's DNA to modify a cell's behavior, such as silencing a gene that should be expressed. Accurately tying the MER11 subfamilies to the markers is a key step to revealing the extent of their impact on gene expression. With that as a springboard, the team tested some 7,000 MER11 sequences from humans and primates, measured how much each one affected gene activity, and found that the youngest MER11 subfamily, G4, had a strong ability to influence gene expression — namely, by bearing its own DNA "motifs" that attract proteins called transcription factors that regulate what genes are switched on and off. "Young MER11_G4 binds to a distinct set of transcription factors, indicating that this group gained different regulatory functions through sequence changes and contributes to speciation," lead author Xun Chen from the Chinese Academy of Sciences said in the statement. The implications are fascinating. Though these strands of DNA may have started as "junk," they have gradually insinuated their way to playing a role in gene regulation today — suggesting a vast portion of unknown evolutionary history that we're only scratching the surface of. "Transposable elements are thought to play important roles in genome evolution, and their significance is expected to become clearer as research continues to advance," Inoue said. More on genetics: Elon Musk Using Eugenics Startup to Inspect DNA of Potential Babies for Intelligence Solve the daily Crossword
Wall Street Journal
6 hours ago
- Wall Street Journal
A Cosmic Mystery: Is China Building the World's Biggest Telescope?
Astronomer Robert Kirshner investigates some of the universe's biggest questions: What happens when a star explodes? Is the universe still expanding? He recently added a new mystery to the list: Is China quietly building the world's biggest telescope? He would like to know, because he leads a rival telescope project in the U.S.
Yahoo
7 hours ago
- Yahoo
A New COVID Variant Is Here, And It's More Transmissible — Here Are The Signs And Symptoms
A new COVID variant known as NB.1.8.1 has made landfall in the United States. As of late May, the variant, which was first detected in China this past January, accounted for 10% of the SARS-CoV-2 sequences tested from around the world, recent surveillance data found. That's a significant jump from 2.5% four weeks prior. A Centers for Disease Control and Prevention (CDC) spokesperson told HuffPost that the agency is in regular contact with international partners about the activity of NB.1.8.1. Up until late May, only 20 NB.1.8.1 sequences had been identified in the U.S. — that's below the threshold needed for a variant to appear on the agency's COVID dashboard. (As soon as its prevalence increases, NB.1.8.1 will pop up on the tracker, the spokesperson added.) It's nerve-wracking to hear that a new variant is making the rounds, but infectious disease specialists say there are no glaring differences between the symptoms of NB.1.8.1 and those caused by other versions of SARS-CoV-2. 'Currently it appears that NB.1.8.1 would have similar symptoms to other COVID variants that have recently been circulating,' Dr. Zachary Hoy, a pediatric infectious disease specialist with Pediatrix Medical Group in Nashville, Tennessee, told HuffPost. Here's what to know about the newest COVID variant that's gaining traction around the world. NB.1.8.1's mutations likely make it more transmissible. Compared to the currently dominant variant in the U.S. (LP.8.1), NB.1.8.1 has a handful of new mutations on the spike protein that may enhance its ability to bind to our cells, according to the World Health Organization (WHO). The agency suspects these mutations will increase the virus's transmissibility and, potentially, diminish the effectiveness of neutralizing antibodies that prevent pathogens from latching to our cells. In other words, the variant may be skilled at dodging some of our immune defenses, research suggests. Here are the signs and symptoms doctors are seeing with NB.1.8.1. According to Dr. Amesh Adalja, an infectious diseases expert and senior scholar at the Johns Hopkins University Center for Health Security, NB.1.8.1's symptoms are pretty much the same as those seen with other SARS-CoV-2 variants. Two of COVID's hallmark symptoms are a mild but persistent dry cough and nasal congestion, Hoy said. Many people who come down with COVID are also hit with fatigue and tiredness. 'An infected person can still make it through the day, but they are resting more and feel more tired throughout the day,' Hoy said. Other common symptoms include a fever, chills, a sore throat and muscle aches. 'Some have described recent variants as less intense symptoms as compared to wintertime influenza viruses, but both can have severe symptoms,' Hoy said. There's no evidence suggesting the variant causes more severe disease or an uptick in hospitalizations or deaths, the WHO states. The only noticeable aspect, as of now, is that it's rising in prevalence, Adalja said. How effective are the vaccines against NB.1.8.1? It's too early to know exactly how effective the shots are — as the research on NB.1.8.1 is limited since it's so new — but scientists expect the shots to hold up well. NB.1.8.1 broke off from the Omicron JN.1 lineage, which the 2024-2025 vaccines target. 'The ability of the vaccines to prevent severe illness is intact though protection versus infection is limited and transient,' Adalja said. Anyone who is at risk of severe disease should stay up-to-date with the shots. 'Those in older populations or with underlying immune disorders or on immune-decreasing medications would benefit more from vaccination or those with increased exposure such as healthcare workers,' Hoy added. So if you have a condition that puts you at risk, it's worth getting vaccinated if it's been more than six months since your last vaccine or bout of COVID, Adalja advises. He also added that those who are low-risk likely do not need to go out and get another shot. Know when to treat NB.1.8.1 at home and when to go visit a doctor. Most people will be able to recover at home by resting and staying hydrated. While you're sick, acetaminophen and ibuprofen can help alleviate muscle aches and fevers, Hoy said. And, in most cases, symptoms should clear up within a week. For those who are at risk for severe disease, including older adults and people who are immune-compromised, it's worth contacting a physician as they can prescribe antivirals — Paxlovid and Molnupiravir — that can significantly lower the risk of severe complications and death. As was the case with previous variants, these antivirals work best when started within five days of symptom onset. As for when you should go to an urgent care or emergency room? When you have chest pain, have a hard time waking up or staying awake, or feel confused and disoriented, the CDC advises. Hoy says the most concerning symptom he warns patients about is difficulty breathing. 'If you have COVID or COVID-like illness and have worsening trouble breathing or chest pain, you should be evaluated at your doctor's office, urgent care or the ER,' he said. Related... RFK Jr. Says COVID Shot Will No Longer Be Advised For Healthy Kids, Pregnant Women COVID Cases Are Rising This Summer, But Not All The Data Shows It — Here's Why People Are Reporting A Frightening COVID Symptom Right Now — Here's What To Know
